Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

What Is the Forecast for the Gene Delivery Technologies Market from 2024 to 2025?

The market size for gene delivery technologies has seen a swift expansion in the past few years. The market, worth $3.79 billion in 2024, is projected to reach a value of $4.3 billion in 2025, marking a Compound Annual Growth Rate (CAGR) of 13.6%. Factors contributing to this growth during the historical period include increased knowledge about genetic diseases, advancements in cell therapy, the development of nanotechnology, an increase in gene therapy trials, and a surge in research funding.

What Is the Projected Market Size of the Gene Delivery Technologies Market?

The market size for gene delivery technologies is projected to experience substantial growth in the coming years, expanding to “$7.44 billion in 2029 with a compound annual growth rate (CAGR) of 14.7%. This growth during the forecast period can be traced back to advancements in precision medicine, improvements in the regulatory framework, the flourishing of gene therapy, and growth of non-viral delivery systems. Key trends for the forecasted period comprise of its application in rare diseases, an increase in clinical trials, drug delivery targeting, expansion of cell therapy, and the development of gene editing instruments.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=10706&type=smp

Who are the Major Competitors in the Gene Delivery Technologies Market Outlook?

Major companies operating in the gene delivery technologies market include Thermo Fisher Scientific Inc., QIAGEN NV, Horizon Discovery Group Co, OriGene Technologies Inc., Oxford Biomedica Solutions LLC, SignaGen Laboratories LLC, Vectalys SAS, Takara Bio Inc., Bio-Rad Laboratories Inc., System Biosciences LLC, Promega Corporation, Hoffmann-La Roche AG, Catalent Inc., Avantor, Pfizer Inc., Becton Dickinson and Company, Novartis AG, Intellia Therapeutics Inc., Editas Medicine Inc., CRISPR Therapeutics AG, Spark Therapeutics Inc., Bluebird Bio Inc., Sarepta Therapeutics Inc., Regenexxbio Inc., Beam Therapeutics Inc., Verve Therapeutics Inc., Arrowhead Pharmaceuticals Inc., Alnylam Pharmaceuticals Inc., Moderna Inc., BioNTech SE, Translate Bio Inc., CureVac N.V., Lonza Group AG

What Is Fueling Growth in the Gene Delivery Technologies Market?

The rising prevalence of cell and gene therapies is predicted to fuel the expansion of the gene delivery technologies market in the future. These therapies are medical procedures that seek to treat or alleviate diseases by modifying a patient’s genetic and cellular constitution. The rise in cell and gene therapies can be attributed primarily to the progression in gene editing technologies, which are vital in the creation and market availability of cell and gene therapies. For example, as per the August 2024 report by the Association of the British Pharmaceutical Industry, a UK-based industry body, the UK medicines regulator traditionally greenlights an average of two ATMPs each year. However, this number is projected to jump to 10-15 approvals per year by 2030. The count of people undergoing these therapies in the UK may rise from 2,500 in 2021 to a potential 10,000 per year by 2028. Consequently, the escalating use of cell and gene therapies fuels the gene delivery technologies market’s growth.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=10706&type=smp

Which Gene Delivery Technologies Market Segments Are Growing the Fastest?

The gene delivery technologies market covered in this report is segmented –

1) By Mode: Biological, Chemical, Physical

2) By Method: Ex Vivo, In Vivo, In Vitro

3) By Application: Gene Therapy, Cell Therapy, Vaccines, Research

Subsegments:

1) By Biological: Viral Vectors, Bacterial Vectors, Lipid Nanoparticles

2) By Chemical: Cationic Lipids, Polymers, Chemical Transfection Agents

3) By Physical: Electroporation, Microinjection, Gene Gun, Sonoporation

Which Industry Trends Are Shaping the Future of the Gene Delivery Technologies Market?

The rise in technological innovations is becoming a prominent trend in the gene delivery technologies market. Industry giants are prioritizing the development of cutting-edge products to solidify their market presence. In February 2023, for example, Aera Therapeutics, an American biotech firm, introduced Aera’s Platform delivery technology aimed at harnessing the power of genetic medicines. Their PNP technology permits detailed targeting of RNA molecules that play a part in disease progression. This technique allows for specific gene editing in a patient’s cells, paving the way for tailor-made gene therapies.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/gene-delivery-technologies-global-market-report

Which Countries Are Leading the Gene Delivery Technologies Market?

North America was the largest region in the gene delivery technologies market in 2024.Asia-Pacific is expected to be the fastest-growing region in the global gene delivery technologies market report during the forecast period. The regions covered in the gene delivery technologies market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=10706

This Report Delivers Insight On:

1. How big is the gene delivery technologies market, and how is it changing globally?

2. Who are the major companies in the gene delivery technologies market, and how are they performing?

3. What are the key opportunities and risks in the gene delivery technologies market right now?

4. Which products or customer segments are growing the most in the gene delivery technologies market?

5. What factors are helping or slowing down the growth of the gene delivery technologies market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 3156230293

Asia +44 2071930708

Europe +44 2071930708

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model